![Francesco Balestrieri](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Francesco Balestrieri
Keine laufenden Positionen mehr
Profil
Francesco Balestrieri served as Chief Executive Officer at Sandoz International GmbH in 2019 and as Director at Sandoz Ltd.
from 2018 to 2019.
He holds a Master's degree in Business Administration from Universita Ca' Foscari di Venezia.
Ehemalige bekannte Positionen von Francesco Balestrieri
Unternehmen | Position | Ende |
---|---|---|
Sandoz International GmbH
![]() Sandoz International GmbH Pharmaceuticals: GenericHealth Technology Sandoz International GmbH develops and manufactures generic pharmaceuticals. It produces finished dosage forms of such off-patent drugs as diabetes treatment Glucophage, GERD drug Prilosec, and cholesterol. The company was founded in 1996 and is headquartered in Holzkirchen, Austria. | Vorstandsvorsitzender | 01.08.2019 |
Sandoz Ltd.
![]() Sandoz Ltd. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Sandoz Ltd. is a British company that develops, produces and markets medicines. The company is based in Camberley, UK and was founded in 1981. | Direktor/Vorstandsmitglied | 22.07.2019 |
Ausbildung von Francesco Balestrieri
Universita Ca' Foscari di Venezia | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Sandoz Ltd.
![]() Sandoz Ltd. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Sandoz Ltd. is a British company that develops, produces and markets medicines. The company is based in Camberley, UK and was founded in 1981. | Health Technology |
Sandoz International GmbH
![]() Sandoz International GmbH Pharmaceuticals: GenericHealth Technology Sandoz International GmbH develops and manufactures generic pharmaceuticals. It produces finished dosage forms of such off-patent drugs as diabetes treatment Glucophage, GERD drug Prilosec, and cholesterol. The company was founded in 1996 and is headquartered in Holzkirchen, Austria. | Health Technology |